Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability

Cancer Letters

Volumn 254, Issue 1, 2007, Pages 42-53

  Miyamoto, Nobuki ^a   Yamamoto, Hiroyuki ^a   Taniguchi, Hiroaki ^a   Miyamoto, Chie ^a   Oki, Mariko ^a   Adachi, Yasushi ^a   Imai, Kohzoh ^a   Shinomura, Yasuhisa ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Gastric cancer; Microsatellite instability; Thrombospondin 1; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; PROTEIN P53; THROMBOSPONDIN 1; VASCULOTROPIN C;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CELL MIGRATION; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METHYLATION; MICROSATELLITE INSTABILITY; NEPHROBLASTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; THBS1 GENE;

ANGIOGENIC PROTEINS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MICROSATELLITE INSTABILITY; MULTIVARIATE ANALYSIS; MUTATION; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; THROMBOSPONDIN 1; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34447331008     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.02.004     Document Type: Article

References (42)

1. Aaltonen L.A., Peltomaki P., Leach F.S., Sistonen P., Pylkkanen L., Mecklin J.P., et al. Clues to the pathogenesis of familial colorectal cancer. Science 260 (1993) 812-816
2. Ionov Y., Peinado M.A., Malkhosyan S., Shibata D., and Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363 (1993) 558-561
3. Thibodeau S.N., Bren G., and Schaid D. Microsatellite instability in cancer of the proximal colon. Science 260 (1993) 816-819
4. Boland C.R., Thibodeau S.N., Hamilton S.R., Sidransky D., Eshleman J.R., Burt R.W., et al. National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 58 (1998) 5248-5257
5. M. Perucho, Correspondence re: C.R. Boland et al., A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer, Cancer Res. 58 (1998) 5248-5257, Cancer Res. 59 (1999) 249--253.
6. Wynter C.V.A., Simms L.A., Buttenshaw R.L., Biden K.G., Young J., Leggett B.A., et al. Angiogenic factor VEGF is decreased in human colorectal neoplasms showing DNA microsatellite instability. J. Pathol. 189 (1999) 319-325
7. Karnes W.E., Shattuck-Brandt R., Burgart L.J., DuBois R.N., Tester D.J., Cunningham J.M., et al. Reduced COX-2 protein in colorectal cancer with defective mismatch repair. Cancer Res. 58 (1998) 5473-5477
8. Sinicrope F.A., Lemoine M., Xi L., Lynch P.M., Cleary K.R., Shen Y., et al. Reduced expression of cyclooxygenase 2 proteins in hereditary nonpolyposis colorectal cancers relative to sporadic cancers. Gastroenterology 117 (1999) 350-358
9. Tsujii M., Kawano S., Tsuji S., Sawaoka H., Hori M., and DuBois R.N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93 (1998) 705-706
10. dos Santos N.R., Seruca R., Constancia M., Seixas M., and Sorbinho-Simoes M. Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology 110 (1996) 38-44
11. Yamamoto H., Perez-Piteira J., Yoshida T., Terada M., Itoh F., Imai K., et al. Gastric cancers of the microsatellite mutator phenotype display characteristic genetic and clinical features. Gastroenterology 116 (1999) 1348-1357
12. Maeda K., Chung Y.S., Ogawa Y., Takatsuka S., Kang S.M., Ogawa M., et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77 (1996) 858-863
13. Renault B., Calistri D., Buonsanti G., Nanni O., Amadori D., and Ranzani G.N. Microsatellite instability and mutations of p53 and TGF-β RII genes in gastric cancer. Hum. Genet. 98 (1996) 601-607
14. Yamamoto H., Itoh F., Fukushima H., Hinoda Y., and Imai K. Overexpression of COX-2 protein is less frequent in gastric cancers with microsatellite instability. Int. J. Cancer 84 (1999) 400-403
15. Kang S.-M., Maeda K., Onoda N., Chung Y.-S., Nakata B., Nishiguchi Y., et al. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int. J. Cancer 74 (1997) 502-507
16. Takahashi Y., Bucana C.D., Cleary K.R., and Ellis L.M. p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int. J. Cancer 79 (1998) 34-38
17. Galy B., Creancier L., Zanibellato C., Prats A.C., and Prats H. Tumor suppressor p53 inhibits human fibroblast growth factor 2 expression by a post-transcriptional mechanism. Oncogene 20 (2001) 1669-1677
18. Li Q., Ahuja N., Burger P.C., and Issa J.P. Methylation and silencing of the thrombospondin-1 promoter in human cancer. Oncogene 18 (1999) 3284-3289
19. Ahuja N., Mohan A.L., Li Q., Stolker J.M., Herman J.G., Hamilton S.R., et al. Association between CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res. 57 (1997) 3370-3374
20. Lawler J. The functions of thrombospondin-1 and -2. Curr. Opin. Cell Biol. 12 (2000) 634-640
21. Jimenez B., Volpert O.V., Crawford S.E., Febbraio M., Silverstein R.L., and Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6 (2000) 41-48
22. Grossfeld G.D., Ginsberg D.A., Stein J.P., Bochner B.H., Esrig D., Groshen S., et al. Thrombospondin-1 expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression. J. Natl. Cancer Inst. 89 (1997) 219-227
23. Dameron K.M., Volpert O.V., Tainsky M.A., and Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265 (1994) 1582-1584
24. Van Meir E.G., Polverini P.J., Chazin V.R., Su Huang H.J., de Tribolet N., and Cavenee W.K. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat. Genet. 8 (1994) 171-176
25. Toyota M., Ahuja M., Suzuki H., Itoh F., Ohe-Toyota M., Imai K., et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res. 59 (1999) 5438-5442
26. Kang G.H., Shim Y.H., Jung H.Y., Kim W.H., Ro J.Y., and Rhyu M.G. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 61 (2001) 2847-2851
27. Oue N., Matsumura S., Nakayama H., Kitadai Y., Taniyama K., Matsusaki K., et al. Reduced expression of the TSP1 gene and its association with promoter hypermethylation in gastric carcinoma. Oncology 64 (2003) 423-429
28. Kanai Y., Ushijima S., Kondo Y., Nakanishi Y., and Hirohashi S. DNA methyltransferase expression and DNA methylation of CpG islands and peri-centromeric satellite regions in human colorectal and stomach cancers. Int. J. Cancer 91 (2001) 205-212
29. Dejong V., Degeorges A., Filleur S.S., Ait-Si-Ali S., Mettouchi A., Bornstein P., et al. The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun. Oncogene 18 (1999) 3143-3151
30. Nishimori H., Shiratsuchi T., Urano T., Kimura Y., Kiyono K., Tatsumi K., et al. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 15 (1997) 2145-2150
31. Verhoef C., de Wilt J.H., and Verheul H.M. Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology. Curr. Pharm. Des. 12 (2006) 2623-2630
32. Hamilton J.P., and Meltzer S.J. A review of the genomics of gastric cancer. Clin. Gastroenterol. Hepatol. 4 (2006) 416-425
33. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324 (1991) 1-8
34. Tanigawa N., Amaya H., Matsumura M., Shimomatsuya T., Horiuchi T., Muraoka R., et al. Extent of tumor vascularization correlates with prognosis and hematogeneous metastasis in gastric carcinomas. Cancer Res. 56 (1996) 2671-2676
35. Kahlenberg M.S., Stoler D.L., Basik M., Petrelli N.J., Rodriguez-Bigas M., and Anderson G.R. p53 tumor suppressor gene status and the degree of genomic instability in sporadic colorectal cancers. J. Natl. Cancer Inst. 88 (1996) 1665-1670
36. Ueki T., Toyota M., Sohn T., Yeo C.J., Issa J.P., Hruban R.H., et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res. 60 (2000) 1835-1839
37. Yang Q.W., Liu S., Tian Y., Salwen H.R., Chlenski A., Weinstein J., et al. Methylation-associated silencing of the thrombospondin-1 gene in human neuroblastoma. Cancer Res. 63 (2003) 6299-6310
38. Oji Y., Ogawa H., Tamaki H., Oka Y., Tsuboi A., Kim E.H., et al. Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn. J. Cancer Res. 90 (1999) 194-204
39. Zhang J., Ito R., Oue N., Zhu X., Kitadai Y., Yoshida K., et al. Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma. Virchows Arch. 442 (2003) 563-568
40. Filleur S., Volpert O.V., Degeorges A., Voland C., Reiher F., Clezardin P., et al. In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects. Genes Dev. 15 (2001) 1373-1382
41. Yu J.L., Rak J.W., Coomber B.L., Hicklin D.J., and Kerbel R.S. Effect of p53 status on tumor response to antiangiogenic therapy. Science 295 (2002) 1526-1528
42. Hoekstra R., de Vos F.Y., Eskens F.A., Gietema J.A., van der Gaast A., Groen H.J., et al. Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer. J. Clin. Oncol. 23 (2005) 5188-5197